Clinical Trials in Smolensk, Russia
Locations / Smolensk, Russia
Delta Trials hosts 577 clinical trials conducted in Smolensk, Russia, making it a notable site of clinical research activity. These trials covering 375 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 46 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Smolensk.
577
Total Trials
375
Conditions
46
Terminated since 2020
Browse by condition (375 total)
- Diabetes mellitus, type 2 25 trialsAll Diabetes mellitus, type 2 trials
- Rheumatoid arthritis 21 trialsAll Rheumatoid arthritis trials
- Asthma 19 trialsAll Asthma trials
- Schizophrenia 15 trialsAll Schizophrenia trials
- COVID-19 14 trialsAll COVID-19 trials
- Arthritis, rheumatoid 14 trialsAll Arthritis, rheumatoid trials
- Epilepsy 14 trialsAll Epilepsy trials
- Multiple sclerosis 12 trialsAll Multiple sclerosis trials
- HIV infections 11 trialsAll HIV infections trials
- Diabetes 11 trialsAll Diabetes trials
- Relapsing remitting multiple sclerosis 11 trialsAll Relapsing remitting multiple sclerosis trials
- Depressive disorder, major 10 trialsAll Depressive disorder, major trials
- Type 2 diabetes mellitus 9 trialsAll Type 2 diabetes mellitus trials
- Psoriatic arthritis 9 trialsAll Psoriatic arthritis trials
- Psoriasis 9 trialsAll Psoriasis trials
- Ulcerative colitis 8 trialsAll Ulcerative colitis trials
- Hepatitis c 8 trialsAll Hepatitis c trials
- Chronic spontaneous urticaria 7 trialsAll Chronic spontaneous urticaria trials
- Stroke 7 trialsAll Stroke trials
- Type 2 diabetes 7 trialsAll Type 2 diabetes trials